Skip to main content

Fosphenytoin Sodium Injection Shortage

Last Updated: January 18, 2024
Status: Current

Products Affected - Description
    • Fosphenytoin sodium solution for injection, Fresenius Kabi, 50 mg phenytoin equivalents/mL, 2 mL single dose vial, 25 count, NDC 63323-0403-02
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Pfizer had Cerebyx on shortage due to increased demand.
Available Products
    • Cerebyx solution for injection, Pfizer, 50 mg phenytoin equivalents/mL, 10 mL single dose vial, 10 count, NDC 00069-6001-21
    • Cerebyx solution for injection, Pfizer, 50 mg phenytoin equivalents/mL, 2 mL single dose vial, 25 count, NDC 00069-6001-25
    • Fosphenytoin sodium solution for injection, Fresenius Kabi, 50 mg phenytoin equivalents/mL, 10 mL single dose vial, 10 count, NDC 63323-0403-10
    • Fosphenytoin sodium solution for injection, Hikma, 50 mg phenytoin equivalents/mL, 10 mL single dose vial, 10 count, NDC 00641-6137-10
    • Fosphenytoin sodium solution for injection, Hikma, 50 mg phenytoin equivalents/mL, 2 mL single dose vial, 25 count, NDC 00641-6136-25

Estimated Resupply Dates

    • Fresenius Kabi has fosphenytoin sodium 2 mL vials on back order and the company cannot estimate a release date.

Updated

Updated January 18, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 14, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.